- Home
- CNET vs QNRX Comparison
CNET vs QNRX Comparison
Compare CNET & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- QNRX
- Stock Information
- Founded
- CNET 2003
- QNRX 2018
- Country
- CNET Hong Kong
- QNRX United States
- Employees
- CNET N/A
- QNRX N/A
- Industry
- CNET Advertising
- QNRX Medical/Dental Instruments
- Sector
- CNET Consumer Discretionary
- QNRX Health Care
- Exchange
- CNET Nasdaq
- QNRX Nasdaq
- Market Cap
- CNET 4.0M
- QNRX 4.3M
- IPO Year
- CNET N/A
- QNRX N/A
- Fundamental
- Price
- CNET $1.52
- QNRX $7.78
- Analyst Decision
- CNET
- QNRX
- Analyst Count
- CNET 0
- QNRX 0
- Target Price
- CNET N/A
- QNRX N/A
- AVG Volume (30 Days)
- CNET 7.9K
- QNRX 2.6K
- Earning Date
- CNET 08-14-2025
- QNRX 11-06-2025
- Dividend Yield
- CNET N/A
- QNRX N/A
- EPS Growth
- CNET N/A
- QNRX N/A
- EPS
- CNET N/A
- QNRX N/A
- Revenue
- CNET $7,688,000.00
- QNRX N/A
- Revenue This Year
- CNET N/A
- QNRX N/A
- Revenue Next Year
- CNET N/A
- QNRX N/A
- P/E Ratio
- CNET N/A
- QNRX N/A
- Revenue Growth
- CNET N/A
- QNRX N/A
- 52 Week Low
- CNET $0.96
- QNRX $5.01
- 52 Week High
- CNET $4.53
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- CNET 54.36
- QNRX 55.81
- Support Level
- CNET $1.20
- QNRX $7.39
- Resistance Level
- CNET $1.60
- QNRX $7.74
- Average True Range (ATR)
- CNET 0.09
- QNRX 0.17
- MACD
- CNET 0.02
- QNRX 0.10
- Stochastic Oscillator
- CNET 72.58
- QNRX 100.00
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.